Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Reviews in Medical Virology|April 13, 2022
Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysisSamuel J Minkove, Junfeng Sun, Yan Li, et al.
Plos One|August 11, 2017
A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and resultsWanying Xu, Lernik Ohanjanian, Junfeng Sun, et al.
Plos One|December 5, 2017
Correction: A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and resultsWanying Xu, Lernik Ohanjanian, Junfeng Sun, et al.
Intensive Care Medicine|June 16, 2006
DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in ratsYan Li, Xuemei Li, Michael Haley, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 10, 2017
Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovirDante A Suffredini, Yan Li, Wanying Xu, et al.
Intensive Care Medicine Experimental|April 23, 2023
Effect of low-to-moderate hyperoxia on lung injury in preclinical animal models: a systematic review and meta-analysisSamuel Minkove, Rhea Dhamapurkar, Xizhong Cui, et al.
Toxins|December 26, 2015
Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical StudiesDante A Suffredini, Hanish Sampath-Kumar, Yan Li, et al.
The Journal of Infectious Diseases|May 19, 2021
Anti-PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus PneumoniaColleen S Curran, Lindsay M Busch, Yan Li, et al.
The Journal of Infectious Diseases|February 16, 2006
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survivalXizhong Cui, Yan Li, Xuemei Li, et al.
Critical Care Medicine|January 8, 2008
Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged miceJunwu Su, Xuemei Li, Xizhong Cui, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Reviews in Medical Virology|April 13, 2022
Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysisSamuel J Minkove, Junfeng Sun, Yan Li, et al.
Plos One|August 11, 2017
A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and resultsWanying Xu, Lernik Ohanjanian, Junfeng Sun, et al.
Plos One|December 5, 2017
Correction: A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and resultsWanying Xu, Lernik Ohanjanian, Junfeng Sun, et al.
Intensive Care Medicine|June 16, 2006
DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in ratsYan Li, Xuemei Li, Michael Haley, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 10, 2017
Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovirDante A Suffredini, Yan Li, Wanying Xu, et al.
Intensive Care Medicine Experimental|April 23, 2023
Effect of low-to-moderate hyperoxia on lung injury in preclinical animal models: a systematic review and meta-analysisSamuel Minkove, Rhea Dhamapurkar, Xizhong Cui, et al.
Toxins|December 26, 2015
Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical StudiesDante A Suffredini, Hanish Sampath-Kumar, Yan Li, et al.
The Journal of Infectious Diseases|May 19, 2021
Anti-PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus PneumoniaColleen S Curran, Lindsay M Busch, Yan Li, et al.
The Journal of Infectious Diseases|February 16, 2006
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survivalXizhong Cui, Yan Li, Xuemei Li, et al.
Critical Care Medicine|January 8, 2008
Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged miceJunwu Su, Xuemei Li, Xizhong Cui, et al.
Pageof 13